Sai Life Sciences Joins the Global ‘COVID Moonshot’ Project

HYDERABAD, India, May 7, 2020 /PRNewswire/ — Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced its collaboration with the COVID Moonshot project that aims to deliver an antiviral drug candidate effective against COVID-19.